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Abstract Predictive modeling of the evolutionary dynamics of cancer is a challenge
issue in computational cancer biology. In this paper, we propose a general mathematical
model framework for the evolutionary dynamics of cancer with plasticity and heterogeneity
in cancer cells. Cancer is a group of diseases involving abnormal cell growth, during which
abnormal regulations in stem cell regeneration are essential for the dynamics of cancer
development. In general, the dynamics of stem cell regeneration can be simplified as a
G0 phase cell cycle model, which lead to a delay differentiation equation. When cell het-
erogeneity and plasticity are considered, we establish a differential-integral equation based
on the random transition of epigenetic states of stem cells during cell division. The pro-
posed model highlights cell heterogeneity and plasticity, and connects the heterogeneity
with cell-to-cell variance in cellular behaviors, e.g., proliferation, apoptosis, and differen-
tiation/senescence, and can be extended to include gene mutation-induced tumor devel-
opment. Hybrid computations models are developed based on the mathematical model
framework, and are applied to the process of inflammation-induced tumorigenesis and tu-
mor relapse after CAR-T therapy. Finally, we give rise to several mathematical problems
related to the proposed differential-integral equation. Answers to these problems are crucial
for the understanding of the evolutionary dynamics of cancer.
Key words: stem cell regeneration; differential-integral equation; cancer development;
computational cancer biology; open problems
1. Introduction
According to the World Health Organization (WHO), cancer has become the first rank-
ing cause of death at ages below 70 years in 48 countries at 2015. Cancer has been a
serious issue for public health. How cancers arise from normal tissues? Why is cancers so
hard to treat? Despite many years researches, people know little about the evolutionary
dynamics of cancer. Multidisciplinary study is required to uncover the mechanism of can-
cer development. Recent years, mathematical oncology–the use of mathematics in cancer
research–has gained momentum with the rapid accumulation of data and applications of
mathematical methodologies[33].
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Cancer is a group of diseases involving abnormal cell growth with the potential to invade
or spread to other parts of the body. Hence, abnormal stem cell regeneration is essential
in cancer development. Many mathematical models of the population dynamics have been
widely studied in understanding how stem cell regeneration is modulated in different con-
text [2, 7, 17, 20, 25, 26, 28, 29, 34, 43, 47]. In most models, the dynamics of a homogeneous
cell pool or the lineage of several homogeneous subpopulations were formulated through a
set of differential equations. Novel experimental techniques developed in recent years allow
us to investigate the heterogeneity of cells at single cell level [4, 8, 10, 16, 37, 45]. The
heterogeneity is mostly originated from random changes of epigenetic state at each cell
cycle, and often induce cell plasticity and diversity which form the main sources of drug
resistance in cancer therapy[11, 21, 40, 32]. Based on the stochastic transition of epigenetic
state during cell division, mathematical models for the heterogeneous population dynam-
ics can be formulated as discrete dynamical system or continuous differentiation-integral
equations [23, 38]. Moreover, hybrid models are often developed to simulate the process
of tumor development and treatment of tumors as multicellular heterogeneous system of
tumors[3].
In this paper, we present a general mathematical framework of modeling the evolution-
ary dynamics of cancer with plasticity and heterogeneity in the cells. We first introduce a
delay differential equation obtained from an age-structure model of G0 phase stem cell re-
generation, and next propose the mathematical formulations for heterogeneous population
dynamics with consideration of epigenetic state transition during cell divisions. Next, we
introduce application of the proposed framework in case studied of cancer development.
Finally, we give rise mathematical problems related to the proposed mathematical model.
Answers to these problems are crucial for understanding the evolutionary dynamics of
cancer.
2. A simple model–G0 cell cycle model
First, we introduce a simple model of stem cell regeneration–the G0 cell cycle model
established by Burns and Tannock in 1970 [2]. This model assumed a resting phase (G0)
between two cell cycles. Stem cells at cell cycling are classified into resting or proliferating
phases (Figure 1). During each cell cycle, a cell in the proliferating phase either undergoes
apoptosis or divides into two daughter cells; however, a cell in the resting phase either
irreversibly differentiates into a terminally differentiated cell or returns to the proliferating
phase. Resting phase cells can also be removed from the stem cell pool due to cell death
or senescence.
Mathematically, the above process can be modeled by an age-structure model for cell
numbers in the resting phase and proliferating phase. Let s(t, a) for the number of stem
cells at the proliferating phase, the age a = 0 is the time of entry into the proliferative
state, and Q(t) the number of resting-phase stem cells. The above assumptions yield the
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G0
κµ
proliferating phase
apoptosis differentiation, death, senescence
proliferation: β(Q)
τ
Figure 1. The G0 model of stem cell regeneration. During stem cell re-
generation, cells in the resting phase either enter the proliferating phase
with a rate β, or be removed from the resting pool with a rate κ due to
differentiation, aging, or death. The proliferating cells undergo apoptosis
with a probability µ.
following partial differential equations[2]
(1)
∇s(t, a) = −µs(t, a), (t > 0, 0 < a < τ)
dQ
dt
= 2s(t, τ)− (β(Q) + κ)Q, (t > 0).
Here ∇ = ∂/∂t + ∂/∂a. The coefficient 2 means that each mother cell generates two
daughter cells after cell division. The boundary condition at a = 0 is as follows:
(2) s(t, 0) = β(Q(t))Q(t),
and the initial conditions are
(3) s(0, a) = g(a), (0 ≤ a ≤ τ); Q(0) = Q0.
Equations (1)-(3) give a general age-structure model of homogeneous stem cell regeneration.
Integrating (1)-(2) through the method of characteristic line, and consider the long-term
behavior (t > τ), we obtain a delay differential equation model [24]
(4)
dQ
dt
= −(β(Q) + κ)Q+ 2e−µτβ(Qτ )Qτ ,
where Qτ (t) = Q(t− τ). This equation describes the general population dynamics of stem
cell regeneration.
The proliferation rate β(Q) describes how cells regulate the self-renewal of stem cells
through secreted cytokines, and is often given by a decrease function of form [1, 25]
(5) β(Q) = β0
θn
θn +Qn
+ β1.
Here, a non-zero constant β1 is included to represent the self-sustained growth signals of
cancer cells[14].
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When β(Q) is given by (5), the equation (4) has a unique positive steady state if and
only if
(6) β0 + β1 > η > β1, here η =
κ
2e−µτ − 1 .
The steady state is given by
(7) Q∗ = η
[
β0 + β1 − η
η − β1
]1/n
.
Therefore, abnormal growth (Q∗ → ∞) may occur when η → β1, i.e., decreasing η (by
decreasing κ or µ) or increasing β1. Hence, the simple G0 cell cycle model (4) implies three
possible conditions for abnormal cell growth: dysregulation in the pathways of differenti-
ation and/or senescence (decreasing κ), sustaining proliferative signaling (increasing β1),
and evasion of apoptosis (decreasing µ). These conditions are well known hallmarks of
cancer [14].
3. A model with cell heterogeneity and plasticity
3.1. Modele equation. The above G0 cell cycle model describes the population dynamics
of homogeneous stem cell regeneration. However, cells are different by their epigenetic
states, including the patterns of DNA methylations, nucleosome histone modifications,
and the transcriptomics. These epigenetic states can change from mother cell to daughter
cells during cell cycling through the re-distribution of modification markers, nucleosome
assembling, or stochastic molecular partitions (Figure 2) [31, 35, 36, 37, 41, 44].
κµ
apoptosis differentiation, death, senescence
proliferation: β(Q)
Figure 2. Illustration of the model for heterogeneous stem cell regenera-
tion. Similar to Figure 1. The heterogeneity is represented by cells with
different colors, and the hence the rate functions are dependent on the epi-
genetic state of the cell.
To model the heterogeneity in stem cells, we introduce a valuable x (often a high dimen-
sional vector) for the epigenetic state of cells, and Ω for the space of all possible epigenetic
states in resting phase stem cells. The epigenetic state x represents intrinsic cellular states
that may change during cell division. Let Q(t,x) the number of stem cells at time t in the
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resting phase with epigenetic state x, the total cell number is given by
(8) Q(t) =
∫
Ω
Q(t,x)dx.
Proliferation of each cell is regulated by the signaling pathways that are dependent on
extracellular cytokines released by all cells in the niche and the epigenetic state x of the
cell[1, 20, 29]. Hence, the proliferation rate β has a form β(Qˆ,x), where Qˆ is the effective
concentration of growth inhibition cytokines given by
(9) Qˆ(t) =
∫
Ω
Q(t,x)ζ(x)dx,
here ζ(x) is the rate of cytokines secretion. Moreover, the apoptosis rate µ, the cell cycle
duration τ , and the differentiation rate κ are dependent on the epigenetic state x, and are
denoted as µ(x), τ(x), and κ(x), respectively.
Moreover, to consider cell plasticity at each cell cycle, we introduce a transition function
p(x,y) for the inheritance probability, which represent the probability that a daughter cell
of state x comes from a mother cell of state y. It is obvious that∫
Ω
p(x,y)dx = 1
for any y ∈ Ω.
Now, similar to (1), when stem cell heterogeneity is include, we obtain the corresponding
age-structure model equation
(10)
∇s(t, a,x) = −µ(x)s(t, a,x), (t > 0, 0 < a < τ(x))
∂Q(t,x)
∂t
= 2
∫
Ω
s(t, τ(y),y)p(x,y)dy − (β(Qˆ(t),x) + κ(x))Q(t,x), (t > 0).
and
s(t, 0,x) = β(Qˆ(t),x)Q(t,x), Qˆ(t) =
∫
Ω
Q(t,x)ζ(x)dx.
Here we note that x can be considered as a parameter for the first equation, hence, we can
apply the characteristic line method and have
s(t, τ(x),x) = β(Qˆ(t− τ(x)),x)Q(t− τ(x),x)e−µ(x)τ(x).
Thus, substituting s(t, τ(x),x) into the second equation in (10), we obtain the following
delay differential-integral equation
(11)

∂Q(t,x)
∂t
= −Q(t,x)(β(Qˆ,x) + κ(x))
+ 2
∫
Ω
β(Qˆτ(y),y)Q(t− τ(y),y)e−µ(y)τ(y)p(x,y)dy,
Qˆ(t) =
∫
Ω
Q(t,x)ζ(x)dx,
Here Qˆτ = Qˆ(t− τ).
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The equation (11) gives the basic dynamical equation of heterogenous stem cell regen-
eration with epigenetic transition. Biologically, the equation (11) connects different scale
components(Figure. 3): the gene expressions at single cell level (x), the population dy-
namic properties (β(Qˆ,x), κ(x), and µ(x)), cell cycle (τ(x)), and epigenetic modification
inheritance (p(x,y)). Thus, this equation provides a framework of mathematical model for
stem cell regeneration, and can be applied to different problems related to cell regenera-
tion, such as development, aging, tumor development, etc. For detail discussions of (11),
referred to [22].
Figure 3. Framework of the the mathematical model of heterogeneous
stem cell regeneration.
3.2. The transition function p(x,y). In the above equation, the transition function
p(x,y) is important to connect cell heterogeneity with plasticity. However, biologically we
cannot measure this function directly, and do not know the possible form neither. Here,
we propose a possible form of the transition function through numerical simulation based
on a computational model of the inheritance of histone modification[18, 19].
Let the epigenetic state x (0 ≤ x ≤ 1) represent the fraction of nucleosomes (in a
segment of DNA sequences), and p(x, y) the probability of a daughter cell with state x
given the mother cell of state y. Simulations based on a computation model of histone
modification/transition suggest that the probability p(x, y) can be approximately described
by a conditional Beta-distribution
p(x, y) =
xa(y)−1(1− x)b(y)−1
B(a(y), b(y))
, B(a, b) =
Γ(a)Γ(b)
Γ(a+ b)
.
Here, the Beta-distribution depends on two shape parameters a and b, which are in turn
dependent on the state y of the mother cell. Hence, the Beta-distribution can be quite
general with different definitions of the functions a(y) and b(y).
EVOLUTIONARY DYNAMICS OF CANCER: FROM EPIGENETIC REGULATION TO CELL POPULATION DYNAMICS—MATHEMATICAL MODEL FRAMEWORK, APPLICATIONS, AND OPEN PROBLEMS7
In general, when the epigenetic state x = (x1, · · · , xn) that includes multiple variables,
we can extend the above Beta-distribution by the multiply rule
p(x,y) =
n∑
i=1
pi(xi,y),
where
pi(xi,y) =
x
ai(y)−1
i (1− xi)bi(y)−1
B(ai(y), bi(y))
.
To determine the functions ai(y) and bi(y), if we write the mean and variance of xi, given
the state y, as
E(xi|y) = φi(y), Var(xi|y) = 1
1 + ηi(y)
φi(y)(1− φi(y)),
through predefined function φi(y) and η(y), the shape parameters are given by
ai(y) = ηi(y)φi(y), bi(y) = ηi(y)(1− φi(y)).
Here, the functions φi(y) and ηi(y) always satisfy
0 < φi(y) < 1, ηi(y) > 0.
As an example, if we consider a situation of one epigenetic state x (0 ≤ x ≤ 1) which
is analogous to the stemness of a cell [27]. The stemness may affect cell proliferation and
differentiations so that the rates β and κ are dependent on the epigenetic state x. Moreover,
we assume that ξ(x) ≡ 1 so that
(12) Qˆ(t) =
∫ 1
0
Q(t, x)dx.
In this case, we have a one dimensional differential-integral equation
(13)
∂Q(t, x)
∂t
= −Q(t, x)(β(Qˆ(t), x)+κ(x))+2e−µτ
∫ 1
0
β(Qˆ(t−τ), y)Q(t−τ, y)p(x, y)dy.
The inheritance probability function p(x, y) is defined as
(14) p(x, y) =
xa(y)(1− x)b(y)
B(a(y), b(y))
, a(y) = η(y)φ(y), b(y) = η(y)(1− φ(y))
with pre-defined functions φ(y) and η(y).
Specifically, we can define [22]
(15) β(Qˆ, x) = β¯ × a1x+ (a2x)
6
1 + (a3x)6
θ
θ + Qˆ
+ β1,
and
(16) κ(x) = κ0 × 1
1 + (b1x)6
.
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The functions β and κ defined by (15) and (16) are taken so that a cell has low proliferation
rate if the stemness if either high or low, and large proliferation rate if the stemness is
intermediate, and the differentiation rate decreases with the stemness.
3.3. Model cancer development with genetic heterogeneity. In the above equa-
tions, we only consider heterogeneous in epigenetic states. However, gene mutations are
important for cancer development, which form intratumoral heterogeneity of cancer cells.
The cells may have diverse combinations of mutations. To model the genetic heterogeneity,
we extend (11) to include mutant types. Assuming that there are m genetic types, we let
Qi(t,x) the cell population with genetic type i (1 ≤ i ≤ m) and epigenetic state x, and pi,j
the mutation rate from genetic type i to type j. Moreover, we assume that mutations only
happen during cell division (DNA replication). Thus, when gene mutations are include,
the equation (11) is rewritten as
∂Qi(t,x)
∂t
= −Qi(t,x)(βi(Qˆ,x) + κi(x))(17)
+ 2(1−
∑
j 6=i
pi,j)
∫
Ω
βi(Qˆτi(y),y)Qi(t− τ(y),y)e−µi(y)τi(y)p(x,y)dy
+ 2
∑
j 6=i
pj,i
∫
Ω
βj(Qˆτ(y),y)Qj(t− τ(y),y)e−µj(y)τj(y)p(x,y)dy,
(1 ≤ i ≤ m)
where
Qˆ(t) =
m∑
i=1
∫
Ω
Qi(t,x)ξ(x)dx.
Equation (17) gives a general equation to include gene mutations. Given the mutant
type combination network pi,j , this equation describes the evolutionary dynamics induced
by gene mutations. Mathematically, the mutation may affect the cell behavior parameters,
so that the rate constants β, κ, µ, and τ are dependent on the mutant types.
4. Applications to the dynamics of cancer development
4.1. Hybrid computational model of multicellular tissues. The equations (11) and
(17) provide general mathematical frameworks to model stem cell regeneration when het-
erogeneity and plasticity in epigenetic or genetic states are included. These frameworks
can be used to described many biological processes associated with stem cell regeneration,
including development, aging, and cancer evolution. Nevertheless, many mathematical
problems associated with the model remain unsolved (to be detailed latter). Both equa-
tions (11) and (17) include integrals over all epigenetic states, and it is expansive to solve
the equations numerically when high dimensional epigenetic states are considered. Thus, in
applications, we often develop hybrid computational models for multicellular tissues based
on the above frameworks. Hybrid models are often used to simulate tumor development
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as complex multicellular heterogeneous systems[3]. Classical hybrid models combine dis-
crete equations to describe individual cells and continuous equations for microenvironment
factors or intercellular components. Now, the field of tumor modeling have reached into
other mathematical areas and combined continuous or discrete models with concepts from
fluid dynamics, game theory, machine learning, or optimization methods to provide more
powerful predictive models[3].
The above mathematical framework suggest a hybrid model that combines discrete sto-
chastic process for the epigenetic/genetic state of individual cells with continues model of
cell population growth (here, we state the numerical scheme for epigenetic state heterogene-
ity, and it is similar when genetic heterogeneity is included). In this model, a multicellular
system is represented by a collection of epigenetic states in each cell as Ωt =
{
[Ci(xi)]
Q(t)
i=1
}
(here Q(t) represents the number of resting-phase stem cells at time t). During a time inter-
val (t, t+ dt), each cell (Ci(xi)) undergoes proliferation, apoptosis, or terminal differential
with a probability given by the kinetic rates (with probability of proliferation, apoptosis, or
differentiation given by β(Qˆ,xi))dt, µ(xi)dt, or κ(xi)dt). Thus, the probabilities of different
cell behaviors are dependent on the epigenetic state of each cells. The total cell number
Q(t) changes after a time step dt in accordance with the behaviors of all cells. When a cell
undergo proliferation, the epigenetic state of daughter cells change randomly according to
the transition function p(x,y). In this hybrid model, all detail molecular interactions are
hidden into the kinetics rates and the transition function. Moreover, we can also include
stochastic process of differential equations for the signaling dynamics within one cell cycle,
as well as microenvironmental variables that may depend on the cell behavior of all cells.
The propose hybrid model can be implement by single-cell-based models through GPU
architecture[39].
4.2. Application to inflammation-induced tumorigenesis. Chronic inflammation is
a serous risk factor for many cancers. Infection-driven chronic inflammation is linked to
approximately 15% of the global cancer burden[9, 6, 30]. Cancer risk increases strongly
with the duration and extent of chronic inflammation[12, 5]. However, the routes from
inflammation to cancer are poorly understood.
In [13], following the above mathematical model framework, we developed a compu-
tation model for inflammation-induced tumorigenesis that combines the major processes
responsible for stem cell regeneration, inflammation, and metabolism-immune balance. In
this model, the population dynamics arise from the dynamics of individual cells, each of
which is based on a model of the cell-cycle dynamics, and the proliferation rate is depen-
dent on the population size. Each cell is associated with individual genetic heterogeneity
due to DNA damage and pathway mutations. DNA damage may occur to a cell under-
going cell division, and trigger the processes of DNA damage repair and cell-cycle arrest
or DNA damage-induced apoptosis when the damaged loci are not successively repaired.
Non-repaired cells can escape from damage-induced apoptosis and reenter the cell cycle
such that over time, damage loci accumulate and eventually induce functional gene muta-
tions in the specific pathways. Mutant cells in the resting phase cell pool can be cleared by
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the immune system due to the metabolism-immune balance. The inflammatory microenvi-
ronment specifically affects the processes of proliferation, apoptosis, and the DNA damage
response. Gene mutations were not considered explicitly in the model; however, the mu-
tations were identified by their effects on the relevant physiologic processes. Mutations to
eight pathways were considered (Table 1), each type mutation occur with a given probabil-
ity at each cell cycle. When a mutation occur to a cell, the corresponding parameter value
changes (either up-regulated or down-regulated) in the cell. Each cell may have different
mutant types.
Table 1. Pathway mutations considered in the model of inflammation-
induce tumorigenesis[13].
Symbol Description
∆Prolif Cell proliferation rate
∆FSProlif Feedback strength to cell proliferation
∆Diff Cell differentiation rate
∆Apop Cell apoptosis rate
∆Damage Probability of DNA damage induction
∆Repair DNA damage repair efficiency
∆Escape Probability of DNA damage-induced cell escape
∆MIB Probability of metabolism-immune balance
Based on model simulations, we are able to reproduce the process of inflammation-
induced tumorigenesis: from normal to precancerous, and from precancerous to malignant
tumors. According to model simulations, starting from serve inflammation, most patients
develop to precancerous with insignificant increase in the cell population in 10 years, and
a few patients may further develop to malignant tumors with signifiant increase in cell
number in latter stages. Moreover, further analysis shown that mutations to the four
pathways, proliferation, apoptosis, differentiation, and metabolism-immune balance, are
crucial for cancer development, and there are multiple pathways of tumorigenesis[13].
4.3. Application to tumor relapse after CAR-T therapy. CAR-T therapy targeting
CD19 has been proved to be an effective therapy for B cell acute lymphoblastic leukemia
(B-ALL). The majority of patients achieve a complete response following a single infusion
of CD19-targeted CAR-T cells; however, many patients suffer relapse after therapy, and
the underlying mechanism remains unclear.
In a recent study[46], we applied second-generation CAR-T cells to mice injected with
leukemic cells; 60% of the mice relapse within 3 months, and the relapsed tumors retained
CD19 expression but exhibited a profound increase in CD34 transcription. Based on these
observations, we develop a single-cell based computation model for the heterogeneous re-
sponse of the tumor cells to the CAR-T treatment.
In the model, we introduced key assumptions that CAR-T induced tumor cells to transi-
tion to hematopoietic stem-like cells (by promoted CD34 expression) and myeloid-like cells
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(my promoted CD123 expression) and hence escape of CAR-T targeting. In the model,
each cell was represented by the epigenetic state of marker genes CD19, CD22, CD34,
and CD123, which play important roles in the CD19 CAR-T cell response and cell lineage
dynamics. The proliferation rate β and differentiation rate κ depend on CD34 expression
level through
β = β0
θ
θ +N
× 5.8[CD34] + (2.2[CD34])
6
1 + (3.75[CD34])6
,
κ = κ0
1
1 + (4.0[CD34])6
.
Here N means the total cell number. The apoptosis rate µ includes a basal rate µ0 and a
rate associated with the CAR-T signal
µ = µ0 + µ1 × Signal,
Signal = f([CD34], [CD123])
γ19[CD19]
1 + γ19[CD19] + γ22[CD22]
R(t),
f([CD34], [CD123]) =
1
(1 + ([CD34]/X0)n0)(1 + ([CD123]/X1)n1)
.
Here R(t) is the predefined CAR-T activity. The expression levels of marker genes changed
randomly following the transition probability of Beta-distributions, and the shape param-
eters were dependent on state of mother cells and the CAR-T signal. For example, given
the expression level of CD34 at cycle k as uk, the expression level at cycle k + 1 (denoted
by uk+1) is a Beta-distribution random number with probability density function
p(u, uk) =
ua(1− u)b
B(a, b)
, B(a, b) =
Γ(a)Γ(b)
Γ(a+ b)
,
with the shape parameters a and b dependent on the average and variance of uk+1. When
E(uk+1) = φ(uk), Var(uk+1) =
1
1 +m
φ(uk)(1− φ(uk)),
then
a = mϕ(uk), b = m(1− ϕ(uk)).
In the model, we assume the average as
φ(uk) = 0.08 + 1.06
(α34uk)
2.2
1 + (α34uk)2.2
,
and let
α34 = 1.45 + 0.16× [CD19] + α34 × Signal
to represent the promotion of CD34 expression by CD19 and the CAR-T signal. For details
of the model, referred to [46].
Model simulations nicely reproduced experimental results, and predicted that CAR-T
cell induced cell plasticity can lead to tumor tumor relapse in B-ALL after CD19 CAR-
T treatment. Simulations and mouse experiments further indicated that CD19 positive
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relapse could be prevented by the combined administration of CD19- and CD123- targeting
CAR-t cells administered at specific ratios.
5. Mathematical problems
The proposed mathematical framework (11) is a delay differential-integral equation that
contains non-local transitions between different epigenetic states. This type equation was
not seen in most physical problems because of the principle of locality. Mathematically,
there are many basic problems remain open for the equation (11). Here, I discuss a few
of them that are basic and important for our understanding of the biological process of
cancer development.
For the simplicity, we omit the delay, and consider the equation with only one dimension
epigenetic state. Hence, we have the following equation
(18)
∂Q(t, x)
∂t
= −Q(t, x)(β(Qˆ, x) + κ(x)) + 2
∫
Ω
β(Qˆ, y)Q(t, y)e−µ(y)p(x, y)dy
Qˆ(t) =
∫
Ω
Q(t, x)ζ(x)dx.
Here x ∈ Ω ⊂ R+, and always assume
(19) β(x) ≥ 0, κ(x) ≥ 0, µ(x) ≥ 0, ζ(x) ≥ 0, 0 ≤ p(x, y) ≤ 1,
and
(20)
∫
Ω
p(x, y)dx = 1, ∀y ∈ Ω.
Here, we note that by omitting the delay, we do not simply set µ = 0 in the equation
(11), but only omit the delays in Q(t− τ(y),y) and Qˆτ(y), and replace e−µ(y)τ(y) by e−µ(y)
with µ(y) the apoptosis rate during the proliferating phase.
5.1. Question 1: Existence and uniqueness of the steady state solution. To con-
sider the steady state solution of (18), let Q(t, x) = Q(x) the steady state, then
(21)

0 = −Q(x)(β(Qˆ, x) + κ(x)) + 2
∫
Ω
β(Qˆ, y)Q(y)e−µ(y)p(x, y)dy
Qˆ =
∫
Ω
Q(x)ζ(x)dx
.
Substituting Qˆ into the first equation, Q(x) satisfies the eigenvalue problem
(22) LQˆ[Q(x)] = 2
∫
Ω
β(Qˆ, y)e−µ(y)p(x, y)Q(y)dy − (β(Qˆ, x) + κ(x))Q(x) = 0.
Thus, the problem of existence and uniqueness of the steady state solution is reduced to
a problem of finding a positive eigenvalue Qˆ of the operator LQˆ so that the corresponding
eigenfunction Q(x) is non-negative for all x ∈ Ω. If such eigenvalue Qˆ exists, the solution of
(21) is given by rescaling the corresponding eigenfunction according to the second equation
in (21).
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In the case of finite discrete epigenetic state, and when the proliferation rate β is inde-
pendent to the epigenetic state, the steady state issue was discussed in [38]. In particular,
if β is independent to the epigenetic state, the eigenvalue problem can be rewritten as
(23) A[Q] =
1
β(Qˆ)
Q,
where A is a linear operator defined as
(24) A[Q] =
1
κ(x)
[
2
∫
Ω
e−µ(y)p(x, y)Q(y)dy −Q(x)
]
.
Thus,
1
β(Qˆ)
is a positive eigenvalue of the operator A. In the case of finite discrete epige-
netic state, the existence for such eigenvalue can be obtained from the Perron-Frobenius
theorem.
If the transition probability p(x, y) is independent to the state of the mother cell, so that
p(x, y) = p(x), the uniqueness and stability of the steady state were further discussed in
[38]. However, it remains open questions for general cases.
Biologically, the states of normal and precancerous correspond to stable steady states
under different conditions. Hence, mathematically identify the existence and stability of
steady states are important for our understanding of the persistence of different states.
5.2. Question 2: Entropy problem. Let
(25) Q(t) =
∫
Ω
Q(t, x)
for the total cell number at time t, and
(26) f(t, x) =
Q(t, x)
Q(t)
for the fraction of cells with given epigenetic state x. The entropy of the multicellular
system at time t is defined as
(27) E(t) = −
∫
Ω
f(t, x) log f(t, x)dx.
A tedious calculation gives
∂f(t, x)
∂t
= −f(t, x)
∫
Ω
f(t, y)
(
(β(fˆQ, x) + κ(x))− (β(fˆQ, y) + κ(y))
)
dy(28)
+ 2
∫
Ω
f(t, y)β(fˆQ, y)e−µ(y) (p(x, y)− f(t, x)) dy,
dQ
dt
= Q
∫
Ω
f(t, x)
(
β(fˆQ, x)(2e−µ(x) − 1)− κ(x)
)
dx,(29)
fˆ =
∫
Ω
f(t, x)ζ(x)dx.(30)
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The derivative of the entropy E(t) is given by
(31)
dE
dt
= −
∫
Ω
∂f(t, x)
∂t
(1 + log f(t, x)) dx.
Here, we replace Qˆ with fˆQ, and have fˆ = 1 when ζ(x) ≡ 1.
The entropy problem asks: how can we decompose the rate of entropy change into
entropy production rate (epr) and entropy dissipate rate (edr) so that
(32)
dE
dt
= epr − edr,
and both epr and edr are alway non-negative.
Solutions to this problem is essential to answer the question of how the entropy change
along the process of tissue development. In particular, is cancer development a process of
entropy increasing[15, 42]?
In the case of homogeneous stem cells, all cells belong to the same epigenetic state, and
hence f(t, x) = 1, and the entropy E(t) ≡ 0. Thus, the entropy do not change over the
development process.
If the epigenetic state transition is omitted, so that p(x, y) = δ(x− y), defining
(33) γ(q, x) = β(q, x)(2e−µ(x) − 1)− κ(x)
as the net production rate of cells with epigenetic state x, we have
(34)
∂f(t, x)
∂t
= f(t, x)γ(fˆQ, x)− f(t, x)
∫
Ω
f(t, y)γ(fˆQ, y)dy,
and
(35)
dE
dt
= ∆E1 −∆E2,
where
(36) ∆E1 = −
∫
Ω
γ(fˆQ, x)f(t, x) log f(t, x)dx, ∆E2 = E(t)
∫
Ω
γ(fˆQ, x)f(t, x)dx.
From (35), for the particular situation that γ(fˆQ, x) > 0 for all x ∈ Ω, we have ∆E1 > 0
and ∆E2 > 0. In this case, ∆E1 gives the entropy production rate, and ∆E2 gives the
entropy dissipation rate.
For the general situation, it is not know how the entropy production rate and dissipation
rate should be defined, and under which situation the development process is entropy
increasing.
5.3. Question 3: Inverse problem. In the propose model, the transition probability
function p(x, y) is usually not known, and cannot be measured directly from experiments.
Hence, it is a challenge issue to estimate this transition function indirectly from experi-
mental data.
In the equations (28)-(29), for the situation of cancer development, we can estimate
the cell number Q(t) (or tumor volume) and the fraction of cells f(t, x) through various
methods, such as imaging, liquid biopsies, biomarker measurement, single-cell sequencing,
EVOLUTIONARY DYNAMICS OF CANCER: FROM EPIGENETIC REGULATION TO CELL POPULATION DYNAMICS—MATHEMATICAL MODEL FRAMEWORK, APPLICATIONS, AND OPEN PROBLEMS15
etc. Hence, the inverse problem of obtaining the rate functions β, κ, µ, and ζ, and the
transition function p(x, y) is essential for the development of personalized predictive model
for cancer development. It was proposed that the merger of mechanistic and machine
learning models has became the future of personalization in mathematical oncology[33].
In this way, we are trying to merger the propose model with the unwieldy multitude of
dispersed data (imaging, tissue, blood, molecular) to estimate the personalized parameter
and to generate optimal clinical decisions for each patient.
5.4. Question 4: Local state transition. In the equations (18) or (18)-(29), the epige-
netic transition function p(x, y) is global. Here, we assume that the epigenetic state can
only have local transition, i.e.,
(37) p(x, y) = ϕ(y − x)
so that ϕ(r) > 0 only when |r| <  1. The function ϕ(r) satisfies
(38)
∫ +∞
−∞
ϕ(r)dr = 1, ϕ(r) ≥ 0, ∀r ∈ R.
We further let
(39) a =
∫ +∞
−∞
rϕ(r)dr, D =
∫ +∞
−∞
r2ϕ(r)dr.
Substituting (37) into (18), and expand the function ϕ to the second order approximation,
we obtain the following close form differential-integral equation
∂f(t, x)
∂t
=
∂
∂x
[(
D
∂
∂x
+ 2a
)(
β(fˆQ, x)e−µ(x)f(t, x)
)]
(40)
+ f(t, x)
(
γ(fˆQ, x)−
∫
f(t, y)γ(fˆQ, y)dy
)
,
dQ
dt
= Q
∫
Ω
f(t, x)γ(fˆQ, x)dx(41)
fˆ =
∫
Ω
f(t, x)ζ(x)dx.(42)
From (40)-(42), the above questions of steady state solution, entropy problem, and
inverse problem can also be formulated as the problem with local transition. For example,
at the steady state, we have ∫
Ω
f(t, x)γ(fˆQ, x)dx = 0,
and the total number Q(t) ≡ Q∗. Hence, the steady state solution (f(t, x) = f(x)) satisfies
a second order differential equation
(43)
d
dx
[(
D
d
dx
+ 2a
)(
β(λ, x)e−µ(x)f(x)
)]
+ γ(λ, x)f(x) = 0,
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with boundary condition (here Ω ⊆ R)
f(x) ≥ 0,
∫
Ω
f(x)dx = 1, Q∗
∫
Ω
f(x)ζ(x)dx = λ.
This equation defines a nonlinear eigenvalue problem for the eigenvalue λ = fˆQ∗.
6. Discussions
Cancer is a group of diseases with abnormal cell growth. This paper provides a general
mathematical framework to describe the dynamics of heterogeneous stem cell regeneration,
and introduce applications of the model to the study of cancer development. The model
highlights the cell heterogeneity and plasticity, and provides a connections between hetero-
geneity with cellular behavior, e.g., proliferation, apoptosis, and differentiation/senescence.
We also extend the model to include gene mutations that are important for cancer devel-
opment. Nevertheless, many other factors may also play important roles in cancer devel-
opment, and are not included in the proposed model, such as the cell-to-cell interactions,
immune cells, microenvironment, spatial information, etc. The current equation should be
extended to included these factors for a more complete model.
The proposed differential-integral equation model provides a general mathematical for-
mulation for the process of stem cell regeneration. This equation integrates different scale
interactions from epigenetic regulation to cell population dynamics. Mathematically, many
basic properties of the proposed differential-integral equation are not known and remain
challenge issues in future studies. Here we propose several mathematical problems that
are basic and important for our understanding of cancer development. We hope that these
equations can be the guideline for related studies in the future.
Finally, the propose model is only a mathematical framework for stem cell regeneration
with heterogeneity and plasticity, detail implementation of the model should be subjected
to specific biological problems.
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